FDA MEETINGS WITH PBM-OWNING MANUFACTURERS

Executive Summary

FDA MEETINGS WITH PBM-OWNING MANUFACTURERS have included personnel drawn from the agency's offices of policy, management and systems, and general counsel in addition to representatives of the drag advertising review division. FDA attendees at separate meetings held in mid- to late-October with Merck, SmithKline Beecham, Pfizer and Lilly included top-level officials from across FDA's organizational structure: Deputy Commissioner/Senior Advisor to the Commissioner Mary Pendergast, Interim Deputy Commissioner for Operations Linda Suydam, Acting Deputy Commissioner for Policy William Hubbard, Center for Drug Evaluation & Research Director Janet Woodcock, MD, and General Counsel Margaret Porter.